Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Voyageur Pharmaceuticals Ltd
VYYRF
Primary Symbol:
V.VM
Healthcare
Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX...
, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (TSXV:VM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Comment by
biggdogg
on Mar 04, 2024 3:17pm
RE:Great interview. Things are definitely moving forward
https://www.paidpromotionalmessages.com/companies/news/1042336/voyageur-pharmaceuticals-teams-with-applied-pharmaceuticals-for-carbon-based-imaging-drugs-1042336.html?region=CA
(53)
•••
whitenorth72
X
View Profile
View Bullboard History
Comment by
whitenorth72
on Mar 04, 2024 2:48pm
RE:Great interview. Things are definitely moving forward
https://www.paidpromotionalmessages.ca/companies/news/1042336/voyageur-pharmaceuticals-teams-with-applied-pharmaceuticals-for-carbon-based-imaging-drugs-1042336.html?region=ca
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(53)
•••
whitenorth72
X
View Profile
View Bullboard History
Post by
whitenorth72
on Mar 04, 2024 2:46pm
Great interview. Things are definitely moving forward
https://www.paidpromotionalmessages.com/companies/news/1042336/voyageur-pharmaceuticals-teams-with-applied-pharmaceuticals-for-carbon-based-imaging-drugs-1042336.html
(2126)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Mar 04, 2024 2:13pm
RE:API Partnership
I read the NR as API doing only the regulatory work for Carbon based contrast products. VM and RC will do the drug development work.
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Mar 04, 2024 11:33am
RE:API Partnership
Do not forget the C60 health product because if it is a reasonable price that could generate many dollars.
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Post by
biggdogg
on Mar 04, 2024 11:06am
API Partnership
These are the types of agreements that will ensure they get financed. They now have proven they have the ability to create new drugs, this is significant. They are truely transforming themselves into
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Mar 04, 2024 10:51am
RE:RE:That should be good
Correct
(53)
•••
whitenorth72
X
View Profile
View Bullboard History
Comment by
whitenorth72
on Mar 04, 2024 10:50am
RE:Voyageur Pharmaceuticals and API Forge Alliance
This is very good news. This agreement should speed up all of Voyageurs projects without further delays and negotiations. A master service agreement (MSA) is a contract that settles the
...more
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Comment by
WarrantOfficer
on Mar 04, 2024 10:48am
RE:That should be good
postie1...Institutional financing should bring the credibility Voyageur requires. Without financing, we have numerous agreements and zero cash flow.
(58)
•••
WarrantOfficer
X
View Profile
View Bullboard History
Post by
WarrantOfficer
on Mar 04, 2024 10:45am
Voyageur Pharmaceuticals and API Forge Alliance
I was pondering Voyageur's next step in our fullerene ambitions. The PR states API is "Industry funded not for profit organization". Will the Master Service Agreement (MSA) cost Voyaguer
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Post by
postie1
on Mar 04, 2024 10:04am
That should be good
This Master Service Agreement (MSA) with Applied Pharma (API) should be good and the more experts the merrier. Hopefully this is only the !st of several announcements to follow shortly. But the big
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 04, 2024 8:30am
New Press Release - Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
(TheNewswire)Calgary, Canada – TheNewswire - March 4, 2024 - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Corporation") and Applied Pharmaceutical Innovation (API), a leading industry-funded not-for-profit organization driving life sciences commercialization, proudly...
read article.
(77)
•••
biggdogg
X
View Profile
View Bullboard History
Post by
biggdogg
on Mar 01, 2024 9:33pm
Industry Can't Keep Up to Iodine Contrast Demand
Voyageur needs to execute its Earth to Bottle Iodine plan sooner than later!! The Industry cant keep up to demand! From GE Healthcare: https://www.gehealthcare.com/insights/article/preventing-future
...more
(76)
•••
postie1
X
View Profile
View Bullboard History
Comment by
postie1
on Mar 01, 2024 4:05pm
RE:RE:RE:RE:RE:RE:Well
I think that shortage was due to virus , was it not? https://www.gehealthcare.com/insights/article/preventing-future-global-shortages-of-iodinated-contrast-media-requires-industry-action
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden